Dr. med. Angelos Rigopoulos

Nach dem Studium der Humanmedizin an der Universität Athen erfolgte die klinische Ausbildung zum Facharzt für Innere Medizin / Kardiologie an der Universitätsklinik für Kardiologie Athen.

Er übernahm am 01.07.2017 eine Oberarztstelle und die Funktion des Herzkatheterlabor-Leiters an der Universitätsklinik und Poliklinik für Innere Medizin III, Kardiologie, Angiologie und Intensivmedizin Halle.

Funktionen in der Klinik:

  • Herzkatheterlabor-Leiter
  • Zuständiger Oberarzt für die Station I8
  • Kardiologische Ambulanz, Herzinsuffizienz-Ambulanz

Klinische Schwerpunkte:

  • Koronarangiographie
  • Komplexe Koronarinterventionen (u.a. Bifurkationsstenosen, Hauptstamm-Stenosen)
  • Intrakoronare Bildgebung mittels intravaskulärem Ultraschall (IVUS) und optical coherence tomography (OCT)
  • Impella-gestützte Koronarinterventionen, kardiogener Schock
  • Rechtsherzkatheteruntersuchungen
  • Alkohol-Septum-Ablation bei hypertroph obstruktiver Kardiomyopathie (ASA-HOCM)
  • TAVI
  • MitraClip

Wissenschaftliche Schwerpunkte:

  • Herzinsuffizienz
  • Kardiomyopathien
  • Klinische Studien nach Arzneimittelgesetz (AMG) und Medizinproduktegesetz (MPG)

Weitere Angaben: 

  • Fellow of the European Society of Cardiology (FESC)
  • Secretary and Nucleus Member of the ESC Working Group for Myocardial and Pericardial Disease (2014-2018)
  • Member of the ESC Congress Programme Committee (2017-2018)


  1. De Vecchis R, Rigopoulos A, Bigalke B, Manginas A, Tschöpe C, et al. Diuretic dosing in heart failure: more data are needed. ESC Heart Fail. 2018 Mar 25;PubMed PMID: 29575802. 
  2. Mavrogeni S, Kolovou G, Bigalke B, Rigopoulos A, Noutsias M, et al. Transplantation in patients with iron overload: is there a place for magnetic resonance imaging? : Transplantation in iron overload. Heart Fail Rev. 2018 Mar;23(2):173-180. PubMed PMID: 29359261. 
  3. Ali M, Lange SA, Wittlinger T, Lehnert G, Behrend S, et al. Direct transfer of STEMI patients to cardiac catheterization laboratory : Prognostic relevance for in-hospital mortality. Herz. 2018 Jan 19;PubMed PMID: 29350253. 
  4. Manginas A, Rigopoulos AG, Bigalke B, Sakellaropoulos S, Ali M, et al. Takotsubo syndrome - adding pieces to a complex puzzle. BMC Cardiovasc Disord. 2017 Dec 20;17(1):296. PubMed PMID: 29262793; PubMed Central PMCID: PMC5738840. 
  5. Rigopoulos AG, Ali M, Sakellaropoulos S, Matiakis M, Teren M, et al. Diagnostic approaches for pericardial effusions : Beyond mere cytopathology. Herz. 2017 Dec 15;PubMed PMID: 29247267. 
  6. Rigopoulos AG, Rizos I, Parissis J. Rate of intramyocardial NCAM re-expression in dilated cardiomyopathy: More pronounced in the left than in the right ventricle?. Int J Cardiol. 2017 Dec 15;249:332. PubMed PMID: 29121738. 
  7. Rigopoulos AG, Ali M, Sakellaropoulos S, Matiakis M, Teren M, et al. Speckle tracking imaging in hypertrophic cardiomyopathy : A powerful tool in search of an unfavorable substrate?. Herz. 2017 Dec 12;PubMed PMID: 29234844. 
  8. Westphal JG, Rigopoulos AG, Bakogiannis C, Ludwig SE, Mavrogeni S, et al. The MOGE(S) classification for cardiomyopathies: current status and future outlook. Heart Fail Rev. 2017 Nov;22(6):743-752. PubMed PMID: 28721466. 
  9. Ali M, Lange SA, Wittlinger T, Lehnert G, Rigopoulos AG, et al. In-hospital mortality after acute STEMI in patients undergoing primary PCI. Herz. 2017 Oct 9;PubMed PMID: 28993843. 
  10. Rigopoulos AG, Bakogiannis C, de Vecchis R, Sakellaropoulos S, Ali M, et al. Acute heart failure : An unmet medical need. Herz. 2017 Sep 22;PubMed PMID: 28939928. 
  11. Caforio ALP, Adler Y, Agostini C, Allanore Y, Anastasakis A, et al. Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease. Eur Heart J. 2017 Sep 14;38(35):2649-2662. PubMed PMID: 28655210. 
  12. Rigopoulos AG, Daci S, Pfeiffer B, Papadopoulou K, Neugebauer A, et al. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy. Clin Res Cardiol. 2016 Nov;105(11):953-961. PubMed PMID: 27270758. 
  13. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J. 2016 Oct 14;37(39):2999-3058. PubMed PMID: 27567407. 
  14. Elliott P, Charron P, Blanes JR, Tavazzi L, Tendera M, et al. European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology. Eur Heart J. 2016 Jan 7;37(2):164-73. PubMed PMID: 26409010. 
  15. Rigopoulos AG, Seggewiss H. Twenty Years of Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy. Curr Cardiol Rev. 2016;12(4):285-296. PubMed PMID: 25563291; PubMed Central PMCID: PMC5304253. 
  16. Rigopoulos AG, Pfeiffer B, Seggewiss H. Serial septal branch assessment in hypertrophic obstructive cardiomyopathy: New echocardiographic contrast agent for alcohol septal ablation. Herz. 2014 Mar;39(2):219-21. PubMed PMID: 23588605. 
  17. Leftheriotis D, Flevari P, Theodorakis G, Rigopoulos A, Ikonomidis I, et al. The Effects of Ranolazine on Paroxysmal Atrial Fibrillation in Patients with Coronary Artery Disease: A Preliminary Observational Study. J Atr Fibrillation. 2014 Feb-Mar;6(5):940. PubMed PMID: 27957034; PubMed Central PMCID: PMC4956122. 
  18. Triantafyllis AS, Kalogeropoulos AS, Rigopoulos AG, Sakadakis EA, Toumpoulis IK, et al. Coronary artery ectasia and inflammatory cytokines: link with a predominant Th-2 immune response?. Cytokine. 2013 Oct;64(1):427-32. PubMed PMID: 23742784. 
  19. Rigopoulos AG, Pfeiffer B, Schimmer C, Illnitzky J, Leyh R, et al. Alcohol septal ablation for recurrent left ventricular outflow tract obstruction after combined myectomy and mitral valve repair in hypertrophic cardiomyopathy. Int J Cardiol. 2013 Jul 31;167(2):e30-2. PubMed PMID: 23608396. 
  20. Anastasakis A, Theopistou A, Rigopoulos A, Kotsiopoulou C, Georgopoulos S, et al. Sudden cardiac death: investigation of the classical risk factors in a community-based hypertrophic cardiomyopathy cohort. Hellenic J Cardiol. 2013 Jul-Aug;54(4):281-8. PubMed PMID: 23912920. 
  21. Rigopoulos AG, Seggewiss H. Hypertrophic cardiomyopathy. Lancet. 2013 Apr 27;381(9876):1456. PubMed PMID: 23622277. 
  22. Pfeiffer B, Rigopoulos A, Seggewiß H. [Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent]. Dtsch Med Wochenschr. 2012 Oct;137(41):2093-6. PubMed PMID: 23033167. 
  23. Kalogeropoulos AS, Tsiodras S, Rigopoulos AG, Sakadakis EA, Triantafyllis A, et al. Novel association patterns of cardiac remodeling markers in patients with essential hypertension and atrial fibrillation. BMC Cardiovasc Disord. 2011 Dec 28;11:77. PubMed PMID: 22204652; PubMed Central PMCID: PMC3276440. 
  24. Toutouzas K, Karanasos A, Anastasakis A, Vavuranakis M, Seggewiss H, et al. Optimal branch selection in alcohol septal ablation. Int J Cardiol. 2011 Feb 17;147(1):143-4. PubMed PMID: 19910065. 
  25. Rigopoulos AG, Seggewiss H. A decade of percutaneous septal ablation in hypertrophic cardiomyopathy. Circ J. 2011;75(1):28-37. PubMed PMID: 21116069. 
  26. Rizos I, Rigopoulos AG, Kalogeropoulos AS, Tsiodras S, Dragomanovits S, et al. Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence. J Hum Hypertens. 2010 Jul;24(7):447-57. PubMed PMID: 20072146. 
  27. Triantafyllidi H, Rizos I, Rallidis L, Tsikrikas S, Triantafyllis A, et al. Aortic distensibility associates with increased ascending thoracic aorta diameter and left ventricular diastolic dysfunction in patients with coronary artery ectasia. Heart Vessels. 2010 May;25(3):187-94. PubMed PMID: 20512445. 
  28. Rigopoulos AG, Panou F, Kremastinos DT, Seggewiss H. Alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Hellenic J Cardiol. 2009 Nov-Dec;50(6):511-22. PubMed PMID: 19942565. 
  29. Paraskevaidis IA, Farmakis D, Papadopoulos C, Ikonomidis I, Parissis J, et al. Two-dimensional strain analysis in patients with hypertrophic cardiomyopathy and normal systolic function: a 12-month follow-up study. Am Heart J. 2009 Sep;158(3):444-50. PubMed PMID: 19699869. 
  30. Seggewiss H, Blank C, Pfeiffer B, Rigopoulos A. Hypertrophic cardiomyopathy as a cause of sudden death. Herz. 2009 Jun;34(4):305-14. PubMed PMID: 19575162. 
  31. Paraskevaidis IA, Panou F, Papadopoulos C, Farmakis D, Parissis J, et al. Evaluation of left atrial longitudinal function in patients with hypertrophic cardiomyopathy: a tissue Doppler imaging and two-dimensional strain study. Heart. 2009 Mar;95(6):483-9. PubMed PMID: 18765436. 
  32. Flevari P, Leftheriotis D, Fountoulaki K, Panou F, Rigopoulos AG, et al. Long-term nonoutflow septal versus apical right ventricular pacing: relation to left ventricular dyssynchrony. Pacing Clin Electrophysiol. 2009 Mar;32(3):354-62. PubMed PMID: 19272066. 
  33. Rigopoulos AG, Papadopoulos C, Ikonomidis I, Rokkas C, Panagiotides JG, et al. Mobile pulmonary valve thrombus as a cause of chronic thromboembolic pulmonary hypertension. Int J Cardiol. 2008 Oct 13;129(3):e81-3. PubMed PMID: 17884197. 
  34. Halapas A, Pissimissis N, Lembessis P, Rizos I, Rigopoulos AG, et al. Molecular diagnosis of the viral component in cardiomyopathies: pathophysiological, clinical and therapeutic implications. Expert Opin Ther Targets. 2008 Jul;12(7):821-36. PubMed PMID: 18554151. 
  35. Seggewiss H, Rigopoulos A, Welge D, Ziemssen P, Faber L. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy. Clin Res Cardiol. 2007 Dec;96(12):856-63. PubMed PMID: 17891517. 
  36. Rizos I, Tsiodras S, Rigopoulos AG, Dragomanovits S, Kalogeropoulos AS, et al. Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome. Cytokine. 2007 Dec;40(3):157-64. PubMed PMID: 17923414. 
  37. Rizos I, Tsiodras S, Papathanasiou S, Rigopoulos A, Barbetseas J, et al. Prosthetic valve endocarditis due to Acinetobacter spp: a rare case and literature review. Am J Med Sci. 2007 Mar;333(3):197-9. PubMed PMID: 17496743. 
  38. Rigopoulos A, Sepp R, Palinkas A, Ungi I, Kremastinos DT, et al. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: collateral vessel communication between septal branches. Int J Cardiol. 2006 Nov 10;113(2):e67-9. PubMed PMID: 16843556. 
  39. Rigopoulos A, Rizos I, Kremastinos DT. Left ventricular noncompaction of the ventricular myocardium: ever a challenging diagnosis. South Med J. 2006 Oct;99(10):1057-8. PubMed PMID: 17100023. 
  40. Anastasakis A, Kotsiopoulou C, Rigopoulos A, Theopistou A, Protonotarios N, et al. Similarities in the profile of cardiopulmonary exercise testing between patients with hypertrophic cardiomyopathy and strength athletes. Heart. 2005 Nov;91(11):1477-8. PubMed PMID: 16230452; PubMed Central PMCID: PMC1769161. 
  41. Miliou A, Anastasakis A, D'Cruz LG, Theopistou A, Rigopoulos A, et al. Low prevalence of cardiac troponin T mutations in a Greek hypertrophic cardiomyopathy cohort. Heart. 2005 Jul;91(7):966-7. PubMed PMID: 15958377; PubMed Central PMCID: PMC1768994. 
  42. Vavuranakis M, Rigopoulos A, Vaina S, Chrysohoou C, Toutouzas K, et al. Lack of increased left main coronary artery dimensions in hypertensive patients with left ventricular hypertrophy and coronary artery disease An intracoronary ultrasound study. Acta Cardiol. 2004 Aug;59(4):397-403. PubMed PMID: 15368801. 
  43. Theopistou A, Anastasakis A, Miliou A, Rigopoulos A, Toutouzas P, et al. Clinical features of hypertrophic cardiomyopathy caused by an Arg278Cys missense mutation in the cardiac troponin T gene. Am J Cardiol. 2004 Jul 15;94(2):246-9. PubMed PMID: 15246915. 
  44. Seggewiss H, Rigopoulos A. [Septal ablation in hypertrophic cardiomyopathy: current status]. Rev Esp Cardiol. 2003 Dec;56(12):1153-9. PubMed PMID: 14670265. 
  45. Anastasakis A, Karandreas N, Stathis P, Rigopoulos A, Theopistou A, et al. Subclinical skeletal muscle abnormalities in patients with hypertrophic cardiomyopathy and their relation to clinical characteristics. Int J Cardiol. 2003 Jun;89(2-3):249-56. PubMed PMID: 12767549. 
  46. Seggewiss H, Rigopoulos A. Management of hypertrophic cardiomyopathy in children. Paediatr Drugs. 2003;5(10):663-72. PubMed PMID: 14510624. 
  47. Rigopoulos A, Rizos IK, Aggeli C, Kloufetos P, Papacharalampous X, et al. Isolated left ventricular noncompaction: an unclassified cardiomyopathy with severe prognosis in adults. Cardiology. 2002;98(1-2):25-32. PubMed PMID: 12373044. 
  48. Karandreas N, Stathis P, Anastasakis A, Rigopoulos A, Piperos P, et al. Electromyographic evidence of subclinical myopathy in hypertrophic cardiomyopathy. Muscle Nerve. 2000 Dec;23(12):1856-61. PubMed PMID: 11102909. 
  49. Manolas J, Kyriakidis M, Anastasakis A, Pegas P, Rigopoulos A, et al. Usefulness of noninvasive detection of left ventricular diastolic abnormalities during isometric stress in hypertrophic cardiomyopathy and in athletes. Am J Cardiol. 1998 Feb 1;81(3):306-13. PubMed PMID: 9468073. Angelos Rigopoulos


Facharzt für Innere Medizin